Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000085156 | SCV001245621 | pathogenic | not provided | 2020-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001383021 | SCV001582029 | pathogenic | Leber congenital amaurosis 2; Retinitis pigmentosa 20 | 2023-11-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu404Alafs*4) in the RPE65 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPE65 are known to be pathogenic (PMID: 9326941, 9501220, 9843205, 18632300). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal recessive inherited retinal dystrophy (PMID: 9501220). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as Glu404(4-bp ins). ClinVar contains an entry for this variant (Variation ID: 98831). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003466996 | SCV004209231 | pathogenic | Leber congenital amaurosis 2 | 2024-03-06 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000085156 | SCV000117293 | not provided | not provided | no assertion provided | not provided |